Kirsty M. McLaughlin

Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP

Leeona Galligan, Daniel B. Longley, Miranda McEwan et al. · Molecular Cancer Therapeutics · 2005 · 157 citations

Life Sciences, Oncology, Pharmacology +17

Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis

Emma Kerr, Caitriona Holohan, Kirsty M. McLaughlin et al. · Cell Death and Differentiation · 2012 · 106 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer

Richard Turkington, Daniel B. Longley, Wendy L. Allen et al. · Cell Death and Disease · 2014 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhanced Antitumor Activity of the Photosensitizer <i>meso</i>-Tetra(<i>N</i>-methyl-4-pyridyl) Porphine Tetra Tosylate through Encapsulation in Antibody-Targeted Chitosan/Alginate Nanoparticles

Sharif Abdelghany, Daniela Schmid, Jill Deacon et al. · Biomacromolecules · 2013 · 78 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery

François Fay, Kirsty M. McLaughlin, Donna M. Small et al. · Biomaterials · 2011 · 68 citations

Pharmacy, Pharmaceutics, Pharmacology +14